220107-42-6Relevant academic research and scientific papers
COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR
-
Paragraph 0146, (2017/08/01)
The present disclosure is directed to disclosed compounds that modulate, e.g., address underlying defects in cellular processing of CFTR activity.
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
-
Page/Page column 46, (2009/01/24)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
Thiazolobenzoheterocycles, preparation and medicines containing same
-
Page column 27, (2010/01/31)
Disclosed are thiazolobenzoheterocycles of the general formula STR1Including their isomers, racemates, enantioners and salts thereof, as well as processes for preparing these compounds and medicaments containing them. Also disclosed are novel intermediates for preparing the foregoing compounds, these intermediates having the formula STR2
